You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

IMPOYZ Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Impoyz patents expire, and what generic alternatives are available?

Impoyz is a drug marketed by Primus Pharms and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-six patent family members in sixteen countries.

The generic ingredient in IMPOYZ is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Impoyz

A generic version of IMPOYZ was approved as clobetasol propionate by COSETTE on February 16th, 1994.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for IMPOYZ?
  • What are the global sales for IMPOYZ?
  • What is Average Wholesale Price for IMPOYZ?
Drug patent expirations by year for IMPOYZ
Pharmacology for IMPOYZ
Paragraph IV (Patent) Challenges for IMPOYZ
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
IMPOYZ Cream clobetasol propionate 0.025% 209483 1 2019-12-06

US Patents and Regulatory Information for IMPOYZ

IMPOYZ is protected by thirteen US patents.

Patents protecting IMPOYZ

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF MODERATE PLAQUE PSORIASIS

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF PLAQUE PSORIASIS

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: PSORIASIS

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER

Topical compositions comprising a corticosteroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF MODERATE PLAQUE PSORIASIS

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: PSORIASIS

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF PLAQUE PSORIASIS

Topical formulations comprising a steroid
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: PLAQUE PSORIASIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Primus Pharms IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Primus Pharms IMPOYZ clobetasol propionate CREAM;TOPICAL 209483-001 Nov 28, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for IMPOYZ

See the table below for patents covering IMPOYZ around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2011026076 ⤷  Sign Up
Mexico 2017011521 COMPOSICIONES TOPICAS QUE COMPRENDEN UN CORTICOSTEROIDE. (TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID.) ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2016145407 ⤷  Sign Up
Russian Federation 2017134440 Композиции для местного применения, содержащие кортикостероид ⤷  Sign Up
European Patent Office 3267978 COMPOSITIONS TOPIQUES COMPRENANT UN CORTICOSTÉROÏDE (TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID) ⤷  Sign Up
South Korea 20200051854 코르티코스테로이드를 포함하는 국소용 조성물 (TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID) ⤷  Sign Up
European Patent Office 2473161 COMPOSITIONS TOPIQUES CONTENANT UN STÉROÏDE (TOPICAL FORMULATIONS COMPRISING A STEROID) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.